Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Financing Activities (2016 - 2026)

Pediatrix Medical (MD) has disclosed Cash from Financing Activities for 17 consecutive years, with -$68.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 1282.99% to -$68.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$107.5 million through Dec 2025, down 642.11% year-over-year, with the annual reading at -$107.5 million for FY2025, 642.11% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$68.6 million at Pediatrix Medical, down from -$28.6 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $108.6 million in Q1 2023, with the low at -$761.7 million in Q1 2021.
  • Average Cash from Financing Activities over 5 years is -$69.8 million, with a median of -$17.3 million recorded in 2025.
  • The sharpest move saw Cash from Financing Activities crashed 63000.76% in 2022, then skyrocketed 142.33% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $825000.0 in 2021, then tumbled by 10559.27% to -$86.3 million in 2022, then soared by 94.5% to -$4.7 million in 2023, then dropped by 4.55% to -$5.0 million in 2024, then tumbled by 1282.99% to -$68.6 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$68.6 million, -$28.6 million, and -$4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.